Clinical Trial Update: Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO) [Phase 2]

View source ↗

Summary

Phase 2 trial of MORAb-004 (MICRO) in colorectal cancer was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• MORAb-004 (MICRO) (MORAb-004)

Snippet

Sponsor: Morphotek | Conditions: Metastatic Colorectal Cancer, Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2022-05-06